Literature DB >> 30101631

Antineoplastic treatment with crizotinib during pregnancy: a case report.

Kristian H Jensen1, Gitte Persson1, Lone Storgaard2, Birgitte B Nielsen2, Berit W Pedersen2, Lisa L Maroun3, Alwin Huitema4,5, Mette Pøhl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30101631     DOI： 10.1080/0284186X.2018.1497302

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

1.  Two Uncomplicated Pregnancies on Alectinib in a Woman With Metastatic ALK-Rearranged NSCLC: A Case Report.

Authors:  Chloe Weidenbaum; Christopher G Cann; Sarah Osmundson; Wade T Iams; Travis Osterman
Journal:  JTO Clin Res Rep       Date:  2022-06-18

2.  Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancer.

Authors:  Lei Yang; Yun-Ting He; Jin Kang; Ming-Ying Zheng; Zhi-Hong Chen; Hong-Hong Yan; Xu-Chao Zhang; Jin-Ji Yang; Yi-Long Wu; Qing Zhou
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

3.  Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis.

Authors:  Zaixiang Fu; Ganggui Zhu; Liquan Wang; Shen Hu; Lu Cheng; Fuyi Liu
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.